Fractyl Health’s Post

View organization page for Fractyl Health, graphic

7,130 followers

The American Diabetes Association (ADA) 84th Scientific Sessions starts today in Orlando, Florida.    We will be presenting new preclinical data for our investigational product REJUVA® on Sunday, June 23rd, from 1:30-1:45 p.m. ET, in the Valencia Ballroom. This abstract was recognized as noteworthy and selected by the Scientific Sessions Meeting Planning Committee as one of eight President’s Select Abstracts. #ADA2024 #ADAScientificSessions #Fractyl #obesity #type2diabetes #T2D #biotech    *Rejuva is in preclinical development and has yet to be assessed by regulatory agencies.     

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics